Search Results 281-290 of 16255 for monoclonal antibody

  1. Pembrolizumab (intravenous route) - Mayo Clinic

    Pembrolizumab is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  2. Mayo Clinic Q&A podcast: Covering COVID-19 in 2021

    Now we have three vaccines in the U.S., and antiviral and monoclonal antibody treatments. That's really incredible." Despite the rapid scientific ...

  3. Dr. Yvonne Butler Tobah Archives - Mayo Clinic News Network

    from Dr. Yvonne Butler Tobah, a Mayo Clinic OB-GYN Monoclonal antibody drugs for cancer Monoclonal antibody drugs use […] The post Living With Cancer ...

  4. Presentations - T Cell Engineering Laboratory - Mayo Clinic Research

    The impact of prior treatment with a CD19 targeting monoclonal antibody on subsequent treatment with CD19 targeting CART cell therapy in preclinical models ...

  5. Health Topics - Mayo Clinic News Network

    What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. COVID-19. What is 'flurona' and why a Mayo Clinic expert ...

  6. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as ...

  7. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

    Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.

  8. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...

  9. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help ... monoclonal antibody including nivolumab and/or any of its excipients. Severe ...

  10. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of ... No history of severe hypersensitivity to a monoclonal antibody. Signed ...